Massimo Negrini

University of Ferrara — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

95h-index56.0kcitations584works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(208), Cancer-related molecular mechanisms research(114), Circular RNAs in diseases(90), Chronic Lymphocytic Leukemia Research(89), RNA modifications and cancer(78)

Publications575 total

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer
Cell Death Discovery·2026· 1 citedOpen Access
TG221: An Experimental Model for Liver Cancer Prevention and Treatment Approaches
BioTech·2026Open Access
P3.12.20 VAF of EGFR Mutations in Relation to Early Tumor Shrinkage or Deepness of Response During Osimertinib in NSCLC Patients
Journal of Thoracic Oncology·2025
Expressed mutated genes in Sezary syndrome and their potential prognostic value in patients treated with extracorporeal photopheresis
Frontiers in Immunology·2025· 1 citedOpen Access
THU-098 miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment
Journal of Hepatology·2025
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
International Journal of Molecular Sciences·2025· 2 citedOpen Access
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation
Cell Death and Disease·2025· 3 citedOpen Access
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
Preprints.org·2025· 1 citedOpen Access
Dupilumab antagonizes the stimulatory effects of IL-13 on mucin production by human bronchial epithelium cells.
2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study
Non-Coding RNA·2024Open Access
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy
Scientific Reports·2024· 7 citedOpen Access
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.
Preprints.org·2024· 2 citedOpen Access
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report
International Journal of Molecular Sciences·2024· 2 citedOpen Access
Connection between MiR-490 and CCND1 and GSK3β genes play an effective role in Wnt signaling pathway in colorectal cancer
Cell Biochemistry and Biophysics·2024· 3 cited
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
European Journal of Immunology·2023· 8 citedOpen Access
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research·2023· 33 citedOpen Access
Data from Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries
2023Open Access
Supplementary Figure 5 from Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <i>In Vitro</i> and <i>In Vivo</i> Evidence
2023Open Access
Supplemental Figure 1 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
2023Open Access
Supplemental Figure 2 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
2023Open Access
page 1 of 29Next →

Frequent Co-authors

Carlo M. Croce(34), Manuela Ferracin(28), George A. Calin(26), Angelo Veronese(14), Chang‐Gong Liu(12), Stefano Volinia(11), Masayoshi Shimizu(11), Hansjüerg Alder(11), Laura Z. Rassenti(9), Silvia Sabbioni(9), Muller Fabbri(9), Laura Gramantieri(9), Giovanni Lanza(8), Francesca Fornari(8), Rosa Visone(7), Amelia Cimmino(6), Thomas J. Kipps(6), Cinzia Sevignani(6), Milena S. Nicoloso(6), Marilena V. Iorio(5)